These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28590781)

  • 1. Cognitive impairment in liver transplanted patients with transthyretin-related hereditary amyloid polyneuropathy.
    Freitas Castro V; Nascimento Alves P; Franco AC; Martins IP; Conceição I
    Amyloid; 2017 Jun; 24(2):110-114. PubMed ID: 28590781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
    Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of liver transplantation on the natural history of oculopathy in Portuguese patients with transthyretin (V30M) amyloidosis.
    Beirão JM; Malheiro J; Lemos C; Matos E; Beirão I; Pinho-Costa P; Torres P
    Amyloid; 2015 Mar; 22(1):31-5. PubMed ID: 25475560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
    Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
    Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with polyneuropathy after liver transplantation.
    Okumura K; Yamashita T; Masuda T; Misumi Y; Ueda A; Ueda M; Obayashi K; Jono H; Yamashita S; Inomata Y; Ando Y
    Amyloid; 2016; 23(1):39-45. PubMed ID: 26763274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases.
    Beirão JM; Malheiro J; Lemos C; Beirão I; Costa P; Torres P
    Amyloid; 2015; 22(2):117-22. PubMed ID: 26096568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Liver transplantation as treatment of familial amyloid polyneuropathy in patients older than 60 years].
    Marcacuzco Quinto AA; Manrique Municio A; Jimenez Romero LC; Loinaz Segurola C; Calvo Pulido J; Justo Alonso I; Garcia-Sesma Perez-F A; Abradelo de Usera M; Cambra Molero F; Caso M O; Moreno Gonzalez E
    Med Clin (Barc); 2015 May; 144(9):385-8. PubMed ID: 24746275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients.
    Hara R; Kawaji T; Ando E; Ohya Y; Ando Y; Tanihara H
    Arch Ophthalmol; 2010 Feb; 128(2):206-10. PubMed ID: 20142544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
    Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
    Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation in transthyretin amyloidosis: issues and challenges.
    Carvalho A; Rocha A; Lobato L
    Liver Transpl; 2015 Mar; 21(3):282-92. PubMed ID: 25482846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of cognitive dysfunction in hereditary transthyretin amyloidosis with liver transplant.
    Cavaco S; Martins da Silva A; Fernandes J; Sousa AP; Alves C; Cardoso M; Teixeira-Pinto A; Coelho T
    Amyloid; 2023 Mar; 30(1):119-126. PubMed ID: 36251860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary amyloidosis related to transthyretin V30M: disease progression in treated and untreated patients.
    Conceição I; Miranda B; Castro J; de Carvalho M
    Eur J Neurol; 2018 Nov; 25(11):1320-e115. PubMed ID: 29924456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life in patients with familial amyloidotic polyneuropathy long-term after liver transplantation.
    Drent G; Graveland CW; Hazenberg BP; Haagsma EB
    Amyloid; 2009; 16(3):133-41. PubMed ID: 19626478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of gastric emptying and gastrointestinal symptoms after liver transplantation for hereditary transthyretin amyloidosis.
    Wixner J; Sundström T; Karling P; Anan I; Suhr OB
    BMC Gastroenterol; 2015 Apr; 15():51. PubMed ID: 25908211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy.
    Waddington Cruz M; Amass L; Keohane D; Schwartz J; Li H; Gundapaneni B
    Amyloid; 2016 Sep; 23(3):178-183. PubMed ID: 27494299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transthyretin-related hereditary amyloidosis].
    Vionnet J; Pascual M; Kuntzer T; Yerly P; Moradpour D
    Rev Med Suisse; 2016 Aug; 12(528):1434-1440. PubMed ID: 28675284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cause of death analysis and temporal trends in survival after liver transplantation for transthyretin familial amyloid polyneuropathy.
    Algalarrondo V; Antonini T; Théaudin M; Chemla D; Benmalek A; Castaing D; Cauquil C; Rouzet F; Mika D; Duong E; Dinanian S; Eliahou L; Le Guludec D; Samuel D; Adams D; Slama MS
    Amyloid; 2018 Dec; 25(4):253-260. PubMed ID: 30632809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy.
    Coutinho MC; Cortez-Dias N; Cantinho G; Conceição I; Oliveira A; Bordalo e Sá A; Gonçalves S; Almeida AG; de Carvalho M; Diogo AN
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):627-36. PubMed ID: 23833285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition.
    Arvidsson S; Pilebro B; Westermark P; Lindqvist P; Suhr OB
    PLoS One; 2015; 10(11):e0143456. PubMed ID: 26600306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Red-flag" symptom clusters in transthyretin familial amyloid polyneuropathy.
    Conceição I; González-Duarte A; Obici L; Schmidt HH; Simoneau D; Ong ML; Amass L
    J Peripher Nerv Syst; 2016 Mar; 21(1):5-9. PubMed ID: 26663427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.